Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Mouse alpha Synuclein ELISA Kit (AC3205)
Cat.#: ASET-1794
Specifications
Description Mouse alpha Synuclein ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse alpha Synuclein concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.028 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1-16 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2295 Rat GABA ELISA Kit (AC3706) Quantitative inquiry ASET-2257 GABA ELISA Kit (AC3668) Quantitative inquiry ASET-1812 Human Dynamin 2 ELISA Kit (AC3223) Quantitative inquiry ASET-1496 Porcine Neuropeptide Y ELISA Kit (AC2907) Quantitative inquiry ASET-2470 Human MAS1L ELISA Kit (AC3881) Quantitative inquiry ASET-1250 Human ASIP ELISA Kit (AC2661) Quantitative inquiry ASET-1126 Human Otoraplin ELISA Kit (AC2537) Quantitative inquiry ASET-1484 Mouse alpha Synuclein ELISA Kit (AC2895) Quantitative inquiry ASET-1634 Human Adenosine Receptor A2a ELISA Kit (AC3045) Quantitative inquiry ASET-1222 Human PDE7B ELISA Kit (AC2633) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket